Conventional procedure | Biochip mosaic | ||
---|---|---|---|
Diagnose | Findings | Diagnose | Findings |
LAD, n = 6 | 2 with linear IgA deposits on salt-split skin, 4 with anti-LAD-1 IgA reactivity | NS, n = 5; pemphigoid, n = 1 | 1 with linear IgG/IgA deposits on salt-split skin; 5 without IR |
p200, n = 5 | linear IgG deposits on salt-split skin and anti-p200 protein/ laminin γ1 reactivity | NS, n = 3; pemphigoid, n = 2 | 2 with linear IgG/IgA deposits on monkey esophagus and salt split skin; 3 without IR |
MMP, n = 6 | 3 with anti-LAD-1 IgG reactivity, 3 with anti-laminin 332 reactivity | NS, n = 4; pemphigoid, n = 2 | 2 with linear IgG/IgA deposits on monkey esophagus and salt-split skin; 4 without IR |
DH, n = 2 | IgA reactivity with endomysium on monkey esophagus and anti-transglutaminase IgA reactivity | NS, n = 2 | no IR |
PNP, n = 2 | Both with anti- Dsg3 reactivity and anti envoplakin reactivity | PV, n = 2 | intercellular IgG/IgA deposits on monkey esophagus and Dsg 3-transfected cells |
BP, n = 2 | positive BP180NC16A ELISA | NS, n = 2 | no IR |
NS, n = 1 | No IR | PV, n = 1 | intercellular IgG/IgA deposits on monkey esophagus and Dsg 3-transfected cells |